These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 15646499)

  • 1. [Usefulness of new vitreous substitutes (F6H6, F6H8) in the vitreoretinal surgery].
    Bernardczyk-Meller J; Pecold K
    Klin Oczna; 2004; 106(4-5):703-5. PubMed ID: 15646499
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Perfluorohexylethan (O62) as ocular endotamponade in complex vitreoretinal surgery.
    Hoerauf H; Roider J; Kobuch K; Laqua H
    Retina; 2005 Jun; 25(4):479-88. PubMed ID: 15933596
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Further evidence for proinflammatory nature of perfluorohexyloctane in the eye.
    Vote B; Wheen L; Cluroe A; Teoh H; McGeorge A
    Clin Exp Ophthalmol; 2003 Oct; 31(5):408-14. PubMed ID: 14516428
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Proliferative Vitreoretinopathy].
    Wiedemann P; Bringmann A
    Klin Monbl Augenheilkd; 2016 Sep; 233(9):1012-5. PubMed ID: 27479581
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of perflubron as a new temporary vitreous substitute and manipulation agent for vitreoretinal surgery. Wills Eye Hospital Perflubron Study Group.
    Banker AS; Freeman WR; Vander JF; Flores-Aguilar M; Munguia D
    Retina; 1996; 16(4):285-91. PubMed ID: 8865387
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Short-term intraocular tamponade with perfluorocarbon heavy liquid.
    Drury B; Bourke RD
    Br J Ophthalmol; 2011 May; 95(5):694-8. PubMed ID: 20934993
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Vitreous substitutes as drug release systems].
    Szurman P; Frank C; Kaczmarek RT; Spitzer MS
    Klin Monbl Augenheilkd; 2009 Sep; 226(9):718-24. PubMed ID: 19750422
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progress in vitreoretinal surgery for proliferative diabetic retinopathy.
    Gotzaridis EV; Lit ES; D'Amico DJ
    Semin Ophthalmol; 2001 Mar; 16(1):31-40. PubMed ID: 15487696
    [No Abstract]   [Full Text] [Related]  

  • 9. New substances for intraocular tamponades: perfluorocarbon liquids, hydrofluorocarbon liquids and hydrofluorocarbon-oligomers in vitreoretinal surgery.
    Kobuch K; Menz IH; Hoerauf H; Dresp JH; Gabel VP
    Graefes Arch Clin Exp Ophthalmol; 2001 Sep; 239(9):635-42. PubMed ID: 11688661
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proliferative vitreoretinopathy.
    Tennant MT; Nelson ML; Blade KA; Garg SJ; Lane RG
    Ophthalmology; 2007 Sep; 114(9):1793-4; author reply 1794-5. PubMed ID: 17822991
    [No Abstract]   [Full Text] [Related]  

  • 11. Perfluorocarbon liquids (perfluorodecalin) in vitreoretinal surgery--a local experience.
    Ong SG; Heng LK; Tan BB; Ang CL; Ang BC
    Ann Acad Med Singap; 1993 May; 22(3):348-50. PubMed ID: 8373117
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proliferative vitreoretinopathy.
    Barile G; Chang S; Schiff W
    Ophthalmology; 2007 Sep; 114(9):1794; author reply 1794-5. PubMed ID: 17822994
    [No Abstract]   [Full Text] [Related]  

  • 13. [Perfluoroctane liquid as a short-term vitreous-retinal tamponade in the postoperative period in patients with retinal detachment due to giant tears].
    Ventura MC; Melo C; Escarião P; Diniz JR; Leão AC
    Arq Bras Oftalmol; 2007; 70(3):495-500. PubMed ID: 17768558
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Relaxing retinopathies and liquid perfluorocarbons].
    Morel C; Doan S; Rivoal O; Ameline B; Monin C; Larricart P
    J Fr Ophtalmol; 1998 May; 21(5):315-20. PubMed ID: 9759424
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Perfluoropropane gas in the management of proliferative vitreoretinopathy.
    Chang S; Coleman DJ; Lincoff H; Wilcox LM; Braunstein RA; Maisel JM
    Am J Ophthalmol; 1984 Aug; 98(2):180-8. PubMed ID: 6476045
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and initial experience with a colored perfluorocarbon liquid for intraocular tamponade in vitreoretinal surgery.
    Rodrigues EB; Shiroma H; Penha FM; Maia M; Moraes-Filho MN; Ferreira M; Portella R; Novais E; Hagedorn N; Farah ME
    Retina; 2014 Jun; 34(6):1103-11. PubMed ID: 24480841
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term outcomes of heavy silicone oil tamponade for complicated retinal detachment.
    Berker N; Batman C; Ozdamar Y; Eranil S; Aslan O; Zilelioglu O
    Eur J Ophthalmol; 2007; 17(5):797-803. PubMed ID: 17932858
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Artificial vitreous replacements.
    Soman N; Banerjee R
    Biomed Mater Eng; 2003; 13(1):59-74. PubMed ID: 12652023
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vitrectomy for proliferative diabetic retinopathy with asteroid hyalosis.
    Ikeda T; Sawa H; Koizumi K; Yasuhara T; Kinoshita S; Tano Y
    Retina; 1998; 18(5):410-4. PubMed ID: 9801034
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anatomical and functional outcomes after heavy silicone oil tamponade in vitreoretinal surgery for complicated retinal detachment: a pilot study.
    Tognetto D; Minutola D; Sanguinetti G; Ravalico G
    Ophthalmology; 2005 Sep; 112(9):1574. PubMed ID: 16139666
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.